Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study

BACKGROUND: Recently, a prospective study reported improved clinical outcomes for recurrent ovarian cancer patients treated with chemotherapies indicated to be sensitive by a chemoresponse assay, compared with those patients treated with non-sensitive therapies, thereby demonstrating the assay'...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tian, C, Sargent, D J, Krivak, T C, Powell, M A, Gabrin, M J, Brower, S L, Coleman, R L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2014
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150278/
https://ncbi.nlm.nih.gov/pubmed/25003664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.375
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak